1
|
Porter J, Parisi D, Miller T, Cheallaigh AN, Miller GJ. Chemical synthesis of amphiphilic glycoconjugates: Access to amino, fluorinated and sulfhydryl oleyl glucosides. Carbohydr Res 2023; 530:108854. [PMID: 37329646 DOI: 10.1016/j.carres.2023.108854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 05/23/2023] [Accepted: 05/23/2023] [Indexed: 06/19/2023]
Abstract
Amphiphilic glycoconjugates offer an important prospect for development as chemical biology tools and biosurfactants. The chemical synthesis of such materials is required to expedite such prospect, compounded by the example of oleyl glycosides. Herein, we report a mild and reliable glycosylation method to access oleyl glucosides, glycosidating oleyl alcohol with α-trichloroacetimidate donors. We demonstrate capability for this methodology, extending it to synthesise the first examples of pyranose-component fluorination and sulfhydryl modifications within glucosides and glucosamines of oleyl alcohol. These compounds provide an exciting series of tools to explore processes and materials that utilise oleyl glycosides, including as probes for glycosphingolipid metabolism.
Collapse
Affiliation(s)
- Jack Porter
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK
| | - Daniele Parisi
- Croda Europe Ltd., Oak Road, Clough Road, Hull, HU6 7PH, UK
| | - Timothy Miller
- Croda Europe Ltd., Oak Road, Clough Road, Hull, HU6 7PH, UK
| | - Aisling Ní Cheallaigh
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK
| | - Gavin J Miller
- Centre for Glycoscience, Keele University, Keele, Staffordshire, ST5 5BG, UK; Lennard-Jones Laboratory, School of Chemical and Physical Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK.
| |
Collapse
|
2
|
Diterpenoid DGA induces apoptosis via endoplasmic reticulum stress caused by changes in glycosphingolipid composition and inhibition of STAT3 in glioma cells. Biochem Pharmacol 2022; 205:115254. [DOI: 10.1016/j.bcp.2022.115254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 08/25/2022] [Accepted: 09/13/2022] [Indexed: 11/20/2022]
|
3
|
Glyco-nanoparticles: New drug delivery systems in cancer therapy. Semin Cancer Biol 2019; 69:24-42. [PMID: 31870939 DOI: 10.1016/j.semcancer.2019.12.004] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 11/28/2019] [Accepted: 12/02/2019] [Indexed: 12/24/2022]
Abstract
Cancer is known as one of the most common diseases that are associated with high mobility and mortality in the world. Despite several efforts, current cancer treatment modalities often are highly toxic and lack efficacy and specificity. However, the application of nanotechnology has led to the development of effective nanosized drug delivery systems which are highly selective for tumors and allow a slow release of active anticancer agents. Different Nanoparticles (NPs) such as the silicon-based nano-materials, polymers, liposomes and metal NPs have been designed to deliver anti-cancer drugs to tumor sites. Among different drug delivery systems, carbohydrate-functionalized nanomaterials, specially based on their multi-valent binding capacities and desirable bio-compatibility, have attracted considerable attention as an excellent candidate for controlled release of therapeutic agents. In addition, these carbohydrate functionalized nano-carriers are more compatible with construction of the intracellular delivery platforms like the carbohydrate-modified metal NPs, quantum dots, and magnetic nano-materials. In this review, we discuss recent research in the field of multifunctional glycol-nanoparticles (GNPs) intended for cancer drug delivery applications.
Collapse
|
4
|
Micellar Iron Oxide Nanoparticles Coated with Anti-Tumor Glycosides. NANOMATERIALS 2018; 8:nano8080567. [PMID: 30044386 PMCID: PMC6116232 DOI: 10.3390/nano8080567] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 07/22/2018] [Accepted: 07/23/2018] [Indexed: 01/02/2023]
Abstract
The synthesis procedure of nanoparticles based on thermal degradation produces organic solvent dispersible iron oxide nanoparticles (OA-IONP) with oleic acid coating and unique physicochemical properties of the core. Some glycosides with hydrophilic sugar moieties bound to oleyl hydrophobic chains have antimitotic activity on cancer cells but reduced in vivo applications because of the intrinsic low solubility in physiological media, and are prone to enzymatic hydrolysis. In this manuscript, we have synthetized and characterized OA-IONP-based micelles encapsulated within amphiphilic bioactive glycosides. The glycoside-coated IONP micelles were tested as Magnetic Resonance Imaging (MRI) contrast agents as well as antimitotics on rat glioma (C6) and human lung carcinoma (A549) cell lines. Micelle antimitotic activity was compared with the activity of the corresponding free glycosides. In general, all OA-IONP-based micellar formulations of these glycosides maintained their anti-tumor effects, and, in one case, showed an unusual therapeutic improvement. Finally, the micelles presented optimal relaxometric properties for their use as T2-weighed MRI contrast agents. Our results suggest that these bioactive hydrophilic nano-formulations are theranostic agents with synergistic properties obtained from two entities, which separately are not ready for in vivo applications, and strengthen the possibility of using biomolecules as both a coating for OA-IONP micellar stabilization and as drugs for therapy.
Collapse
|
5
|
Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012. MASS SPECTROMETRY REVIEWS 2017; 36:255-422. [PMID: 26270629 DOI: 10.1002/mas.21471] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2014] [Accepted: 01/15/2015] [Indexed: 06/04/2023]
Abstract
This review is the seventh update of the original article published in 1999 on the application of MALDI mass spectrometry to the analysis of carbohydrates and glycoconjugates and brings coverage of the literature to the end of 2012. General aspects such as theory of the MALDI process, matrices, derivatization, MALDI imaging, and fragmentation are covered in the first part of the review and applications to various structural types constitute the remainder. The main groups of compound are oligo- and poly-saccharides, glycoproteins, glycolipids, glycosides, and biopharmaceuticals. Much of this material is presented in tabular form. Also discussed are medical and industrial applications of the technique, studies of enzyme reactions, and applications to chemical synthesis. © 2015 Wiley Periodicals, Inc. Mass Spec Rev 36:255-422, 2017.
Collapse
Affiliation(s)
- David J Harvey
- Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, OX1 3QU, UK
| |
Collapse
|
6
|
Romero-Ramírez L, García-Álvarez I, Casas J, Barreda-Manso M, Yanguas-Casás N, Nieto-Sampedro M, Fernández-Mayoralas A. New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase. Biochem Pharmacol 2015. [DOI: 10.1016/j.bcp.2015.07.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
7
|
García-Álvarez I, Garrido L, Romero-Ramírez L, Nieto-Sampedro M, Fernández-Mayoralas A, Campos-Olivas R. The effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopy. PLoS One 2013; 8:e78391. [PMID: 24194925 PMCID: PMC3806797 DOI: 10.1371/journal.pone.0078391] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2013] [Accepted: 09/20/2013] [Indexed: 12/21/2022] Open
Abstract
The effect of the treatment with glycolipid derivatives on the metabolic profile of intact glioma cells and tumor tissues, investigated using proton high resolution magic angle spinning (1H HR-MAS) nuclear magnetic resonance (NMR) spectroscopy, is reported here. Two compounds were used, a glycoside and its thioglycoside analogue, both showing anti-proliferative activity on glioma C6 cell cultures; however, only the thioglycoside exhibited antitumor activity in vivo. At the drug concentrations showing anti-proliferative activity in cell culture (20 and 40 µM), significant increases in choline containing metabolites were observed in the 1H NMR spectra of the same intact cells. In vivo experiments in nude mice bearing tumors derived from implanted C6 glioma cells, showed that reduction of tumor volume was associated with significant changes in the metabolic profile of the same intact tumor tissues; and were similar to those observed in cell culture. Specifically, the activity of the compounds is mainly associated with an increase in choline and phosphocholine, in both the cell cultures and tumoral tissues. Taurine, a metabolite that has been considered a biomarker of apoptosis, correlated with the reduction of tumor volume. Thus, the results indicate that the mode of action of the glycoside involves, at least in part, alteration of phospholipid metabolism, resulting in cell death.
Collapse
Affiliation(s)
- Isabel García-Álvarez
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
- * E-mail: (IG-A); (RC-O)
| | - Leoncio Garrido
- Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Lorenzo Romero-Ramírez
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto Cajal de Neurobiología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Manuel Nieto-Sampedro
- Unidad de Neurología Experimental, Hospital Nacional de Parapléjicos, Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
- Instituto Cajal de Neurobiología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Alfonso Fernández-Mayoralas
- Instituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
| | - Ramón Campos-Olivas
- Spectroscopy and NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Center (CNIO), Madrid, Spain
- * E-mail: (IG-A); (RC-O)
| |
Collapse
|
8
|
Zhang Y, Liu L, Daneshfar R, Kitova EN, Li C, Jia F, Cairo CW, Klassen JS. Protein–Glycosphingolipid Interactions Revealed Using Catch-and-Release Mass Spectrometry. Anal Chem 2012; 84:7618-21. [DOI: 10.1021/ac3023857] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Yixuan Zhang
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Lan Liu
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Rambod Daneshfar
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Elena N. Kitova
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Caishun Li
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Feng Jia
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - Christopher W. Cairo
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| | - John S. Klassen
- Alberta Glycomics
Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada T6G
2G2
| |
Collapse
|
9
|
García-Álvarez I, Groult H, Casas J, Barreda-Manso MA, Yanguas-Casás N, Nieto-Sampedro M, Romero-Ramírez L, Fernández-Mayoralas A. Synthesis of Antimitotic Thioglycosides: In Vitro and in Vivo Evaluation of Their Anticancer Activity. J Med Chem 2011; 54:6949-55. [DOI: 10.1021/jm200961q] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Isabel García-Álvarez
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
| | - Hugo Groult
- Instituto de Química Orgánica General, CSIC, Juan de la Cierva, 3, 28006 Madrid, Spain
| | - Josefina Casas
- RUBAM Institut de Química Avançada de Catalunya, CSIC, Jordi Girona, 18, 08034 Barcelona, Spain
| | - M. Asunción Barreda-Manso
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Natalia Yanguas-Casás
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Manuel Nieto-Sampedro
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | - Lorenzo Romero-Ramírez
- Hospital Nacional de Parapléjicos, SESCAM, Finca la Peraleda s/n, 45071 Toledo, Spain
- Instituto Cajal, CSIC, Avda. Doctor Arce 37, 28002 Madrid, Spain
| | | |
Collapse
|